CL4 showed an expression profile hierarchically linked to neuroendocrine carcinomas (LCNECs and SCLCs), with the greatest number of cases with simultaneous inactivation of TP53 and RB1, and a transcriptomic profile associated with hypomethylation-related signatures. Here, RB1 is linked to neuroendocrine carcinoma.